The North American metal stamping for electronics market continues to expand steadily. In 2024, it was valued at approximately USD 15.56 billion and is projected to reach USD 24.56 billion by 2033, growing at a CAGR of 5.3%. Growth is driven by rising demand for precision metal components in consu...Read More »
October 10, 2025
Olaparib (Lynparza), developed by AstraZeneca and Merck, is a leading PARP inhibitor approved for the treatment of ovarian, breast, prostate, and pancreatic cancers. With global revenues reaching approximately USD 3.67 billion in 2024, Lynparza has established itself as a top-performing oncology t...Read More »
October 9, 2025
Bevacizumab, marketed as Avastin by Genentech (a Roche subsidiary), has become a cornerstone treatment for oncology indications, including metastatic colorectal cancer, non-small cell lung cancer, and glioblastoma. Its strong market performance has been driven by its anti-angiogenic efficacy and e...Read More »
October 8, 2025
Eculizumab, marketed as Soliris by Alexion Pharmaceuticals, is a critical treatment for rare and life-threatening conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). Its unique mechanism of action, as a complement inhibitor, has positioned it...Read More »
October 8, 2025
Secukinumab (Cosentyx), developed by Novartis, is a leading IL-17A inhibitor approved for multiple immune-mediated conditions, including plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, and hidradenitis suppurativa, making it a cornerstone of...Read More »
October 7, 2025
Nivolumab, marketed as Opdivo by Genentech (a Roche subsidiary), has become a cornerstone treatment for oncology indications, including metastatic colorectal cancer, non-small cell lung cancer, and glioblastoma. Its strong market performance has been driven by its anti-angiogenic efficacy and exte...Read More »
October 7, 2025
Non-hospital imaging (mobile radiography, mobile mammography, point-of-care ultrasound, mobile CT/MRI trailers, and teleradiology) is expanding rapidly, driven by aging populations and long-term care needs, rural and underserved population demand, workforce shortages and hospital capacity constrai...Read More »
October 6, 2025
Enhertu, marketed as Enhertu by Daiichi Sankyo and AstraZeneca, has become a key therapeutic for HER2-positive and HER2-low cancers, including advanced breast cancer, metastatic non-small cell lung cancer (NSCLC), and gastric cancer, with strong market performance driven by its targeted mechanism ...Read More »
October 3, 2025
Pembrolizumab (Keytruda), developed by Merck & Co., has transformed the oncology landscape as a PD?1 immune checkpoint inhibitor approved for multiple cancers, including NSCLC, melanoma, head and neck squamous cell carcinoma, and urothelial carcinoma. With global revenues exceeding USD 29 bill...Read More »
October 3, 2025
Ustekinumab, marketed as Stelara by Janssen Biotech, has become a cornerstone treatment for autoimmune conditions, including psoriasis, Crohn's disease, and psoriatic arthritis. Its strong market performance has been driven by its proven efficacy and broad therapeutic applications. As the expirati...Read More »
September 30, 2025
The healthcare third-party logistics (3PL) market is experiencing significant growth due to increased production of pharmaceuticals and medical devices and the globalization of clinical trials. In addition, the increasing prevalence of chronic diseases has led to rising demand for the temperature-...Read More »
September 30, 2025
Aflibercept (Eylea) is a key anti-VEGF therapy used to treat wet age-related macular degeneration, diabetic macular edema, diabetic retinopathy, and retinal vein occlusion. It is widely adopted due to its strong efficacy and convenient dosing schedule compared with other anti-VEGF agents. Market g...Read More »
September 30, 2025
Electrical Impedance Tomography (EIT) is a non-invasive, radiation-free medical imaging method that sends small electrical currents through surface electrodes, measures the resulting voltages, and creates images of tissue conductivity. Unlike traditional imaging techniques like CT or MRI, EIT prov...Read More »
September 30, 2025
The Risankizumab (Skyrizi) market is experiencing notable developments, influenced by evolving regulatory standards, increasing demand, and shifting competitive dynamics within the pharmaceutical industry. As the market expands, it is essential to consider factors impacting its growth trajectory, ...Read More »
September 29, 2025
The escalating U.S. tariff regime and global trade tensions are reshaping the veterinary sector, exerting pressure on input costs, supply chain stability, service affordability, and long-term industry planning. The September 26, 2025, announcement imposing a 100% tariff on branded and patented pha...Read More »
September 29, 2025
Rivaroxaban, marketed as Xarelto, has been a leading treatment in the anticoagulant market, widely used for conditions such as atrial fibrillation, deep vein thrombosis, and pulmonary embolism. With its proven clinical efficacy, Xarelto has maintained a strong market presence globally. However, as...Read More »
September 29, 2025
Semaglutide, branded as Ozempic by Novo Nordisk, has become a key therapeutic for type 2 diabetes, with strong market performance due to its efficacy in blood sugar control. However, as the expiration of its patent approaches, the market for Ozempic is set to undergo significant changes. The impen...Read More »
September 26, 2025
The Biktarvy market is experiencing notable developments, influenced by evolving regulatory standards, increasing demand, and shifting competitive dynamics within the pharmaceutical industry. As the market expands, it is essential to consider factors impacting its growth trajectory, emerging trend...Read More »
September 26, 2025
The global animal population is growing steadily, driven by rising pet ownership and expanding livestock demand. Companion animals, particularly dogs and cats, are increasingly integrated into households, with ownership surging across the U.S., UK, Australia, Mexico, and UAE, reflecting shifting d...Read More »
September 23, 2025
The global hernia surgery and devices market is experiencing rapid growth, fueled by increased hernia cases and heightened awareness of early diagnosis. The Cleveland Clinic estimates that approximately 20 million hernia surgeries are performed worldwide each year, including procedures like inguin...Read More »
September 22, 2025